RE: No Change Then12 Apr 2022 02:27
@Rifleman. NCYT did not back the wrong horse, they have sold the more reliable OCR tests that were needed to confirm cases after unreliable and cheaper LFTs. It would not matter what route they went down, the result would be the same. The gov mainly avoided the UK diagnostic sector despite singing their praises. The fact the gov. have now started approving various tests from uk Co's after the event is just a token jesture....until the next wave hits. Despite NCYTs low SP, they are in a far better state than most if not all of the other UK COs that came to the Govs rescue in the beginning. All have been shafted, the main difference is NCYT are becoming world known for being 1st to market identifying each new strain, and also the little matter of £100m in the bank, not nany others can say that...